Key result
Alzheimer's disease progression is linked to 12 distinct microglial transcriptional states.
Observational (n=443)
Answers are grounded in this paper and cite their sources.
Altered microglial states affect neuroinflammation, neurodegeneration, and disease but remain poorly understood. Here, we report 194,000 single-nucleus microglial transcriptomes and epigenomes across 443 human subjects and diverse Alzheimer's disease (AD) pathological phenotypes. We annotate 12 microglial transcriptional states, including AD-dysregulated homeostatic, inflammatory, and lipid-processing states. We identify 1,542 AD-differentially-expressed genes, including both microglia-state-specific and disease-stage-specific alterations. By integrating epigenomic, transcriptomic, and motif information, we infer upstream regulators of microglial cell states, gene-regulatory networks, enhancer-gene links, and transcription-factor-driven microglial state transitions. We demonstrate that ectopic expression of our predicted homeostatic-state activators induces homeostatic features in human iPSC-derived microglia-like cells, while inhibiting activators of inflammation can block inflammatory progression. Lastly, we pinpoint the expression of AD-risk genes in microglial states and differential expression of AD-risk genes and their regulators during AD progression. Overall, we provide insights underlying microglial states, including state-specific and AD-stage-specific microglial alterations at unprecedented resolution.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2023) conducted an observational in Alzheimer's disease (n=443). Alzheimer's disease pathological phenotypes was evaluated on Microglial transcriptional states and differentially-expressed genes. Alzheimer's disease progression was associated with 12 distinct microglial transcriptional states and 1,542 differentially-expressed genes across 443 human subjects.
Synapse has enriched 10 related papers. Consider them for comparative context: